Press Releases
ZUNVEYL® net product revenue increased approximately 71% quarter-over-quarter to $6.0 million in the second quarter of 2026.
Bottles dispensed increased approximately 37% quarter-over-quarter to 8,294, with monthly demand reaching 2,997 in June.
Quarterly prescribers increased approximately 26% to 1,347 and repeat prescribers increased approximately 29% to 1,024, with approximately 76% prescribing in multiple months.
Cash and cash equivalents totaled $41.4... (continue reading...)
2026 Second Quarter and Recent Highlights
- Revenue of $37.8 million in line with expectations
- Net loss of $4.6 million and Adjusted net income of $2.5 million
- Adjusted EBITDA of $7.7 million in line with expectations
- Operating cash flow of $1.8 million inclusive of $7.6 million in Odds Holdings deferred consideration payments
- Adjusted free cash flow of $9.6 million
- May 2026 restructuring supports expanded margins in second half of the year
- 2026 full... (continue reading...)
BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to Ms. Beth Rada, the Company’s new SVP, Government Affairs and Public Policy. The awards were made as an inducement material to the recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement... (continue reading...)
Second quarter revenue increases 244% to $41.3 million. Net Loss of $1.8 million; Adjusted EBITDA of $3.0 million. Cash increases to $23.2 million.
BOULDER, Colo.--(BUSINESS WIRE)-- Laird Superfood, Inc. (NYSE American: LSF) (“Laird Superfood,” the “Company,” “we,” and “our”), today reported financial results for the second quarter ended June 30, 2026.
Jason Vieth, Chief Executive Officer, commented, “Q2 was another transformational quarter for Laird Superfood... (continue reading...)
BUENOS AIRES, Argentina--(BUSINESS WIRE)--
Banco BBVA Argentina S.A. (NYSE; BYMA; MAE: BBAR; LATIBEX: XBBAR) today announced that it will report its Second Quarter 2026 financial results.
Earnings Release Thursday, Aug 27, 2026 Time: After market close
Conference Call Friday, Aug 28, 2026 Time: 12:00 p.m. Buenos Aires time – (11:00 a.m. EST)
Quiet Period From Thursday, Aug 13, through Thursday, Aug 27, 2026
Executives Ms. Carmen Morillo Arroyo, CFO Mr.... (continue reading...)
More Press Releases
View Older Stories-
FIRY Reports Second Quarter 2026 Results
-
PagerDuty to Report Second Quarter Fiscal Year 2027 Results on August 27, 2026
-
Enhanced Group, Inc. Reports Second Quarter 2026 Results
-
CapsoVision Reports Second Quarter 2026 Financial Results
-
Veritone Reports Second Quarter 2026 Results and Provides Update on Cost Reductions
-
Nuclea Energy to Acquire Moltex Advanced Nuclear Technology Platform
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
-
HealthWarehouse.com Reports Results for Second Quarter 2026
-
Abacus Global Management, Inc. Announces $100 Million Share Repurchase Program
-
Docusign to Announce Second Quarter Fiscal 2027 Financial Results on September 3, 2026
-
Genasys Inc. Reports Fiscal Third Quarter 2026 Results
-
Digimarc Reports Second Quarter 2026 Financial Results
-
Vuzix Reports Second Quarter 2026 Results
-
DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2026 RESULTS
-
Xylem Appoints D. Christian Koch to Board of Directors
-
Vontier Declares Regular Dividend
-
Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08
-
Heritage Global Inc. Reports Second Quarter 2026 Results
-
Intellicheck Reports Second Quarter 2026 Results
-
Ulta Beauty to Report Second Quarter Fiscal 2026 Results on August 27, 2026
-
Boqii Holding Limited Provides Response to Unusual Market Action
-
AIG Expands Cyber Insurance Offering to Help Businesses Manage Cloud Outage Risks
-
Birchtech Reports Second Quarter 2026 Financial Results
-
dLocal Reports Second Quarter 2026 Financial Results
-
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
-
AVAX One Reports Second Quarter 2026 Financial and Operating Results
-
Workhorse Group Reports Second Quarter 2026 Results
-
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
-
RLI Declares Regular Dividend
-
Clarity Systems Closes Seed Round Led by LMnT Ventures to Tackle Returns Fraud
-
Jefferson Capital Reports Second Quarter 2026 Results
-
Roadzen Delivers Best Quarter in Company History with Record Q1 FY2027 Revenue of $16.2 Million, Up 49% Year-Over-Year
-
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
-
PEDEVCO Reports Second Quarter 2026 Results
-
Build-A-Bear Workshop to Announce Second Quarter Fiscal 2026 Results and Host Investor Conference Call on August 27, 2026
-
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
-
Midera Food Processing Reports Second Quarter 2026 Results in First Report as an Independent Public Company
-
Cibus Reports Second Quarter Financial Results and Provides Business Update
-
Parsons Awarded $70M to Advance Air Base Air Defense Capabilities Across Europe and Africa
-
HireQuest, Inc. Declares Quarterly Dividend
-
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
-
Merlin, Inc. Reports Second Quarter 2026 Results
-
ROC Reports Second-Quarter 2026 Revenue Doubled Sequentially; Steady Government Contract Activity Delivers 41% YoY R&D Revenue Growth
-
Swarmer Reports Second Quarter 2026 Financial Results and Provides Business Update
-
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
-
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Beeline Q2 2026 Revenue Increases 57% Year-Over-Year; Net Loss Narrows 24% vs. Q1 2026
-
WidePoint Reports Second Quarter 2026 Financial Results
-
Firefly Aerospace Awarded Contract to Design Elytra Deorbit System for Defense Innovation Unit
-
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

